Clinical Trial Update: Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing interferon alfa-2a versus cyclosporin A in severe ocular Behçet's disease (panuveitis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease
• Panuveitis
• Posterior Uveitis
• Retinal Vasculitis

Drugs mentioned

• Cyclosporin A (cyclosporine)
• Interferon alfa-2a (interferon alfa-2a)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Behcet's Disease, Panuveitis | Phase 3 | Status: COMPLETED